Bone re/modeling is more dynamic in the endothelial nitric oxide synthase(-/-) mouse

F. Grassi, X. Fan, J. Rahnert, M. N. Weitzmann, R. Pacifici, M. S. Nanes, J. Rubin

Research output: Contribution to journalArticle

Abstract

Nitric oxide is a ubiquitous estrogen-regulated signaling molecule that has been implicated in the regulation of bone maturation and remodeling. To better understand the role that bone-cell-secreted nitric oxide plays in ovariectomy-induced modifications of bone turnover, we examined the expression of endothelial NO synthase (eNOS) in bone cells and bone progenitor cells at regular intervals up to 10 wk after acute estrogen deprivation. Ovariectomy led to an anticipated initial decline in bone cell eNOS production, but surprisingly, 17 d after ovariectomy, eNOS expression by bone and marrow stromal cells dramatically rebounded and was maintained at high levels for at least 10 wk after surgery. We examined the long-term consequences of eNOS in the process of ovariectomy-induced bone loss by prospectively analyzing bone mineral density in wild-type and eNOS(-/-) mice for 10 wk after ovariectomy. Ovariectomized eNOS(-/-) mice were observed to undergo an exaggerated state of estrogen-deficiency-induced bone remodeling compared with wild-type controls, suggesting that eNOS may act to mitigate this process. Furthermore, we found that whereas bone formation in estrogen-replete wild-type mice slowed between 14 and 20 wk of age, eNOS knockout mice continued to accrue basal bone mass at a high rate and showed no sign of entering a remodeling stage. Our data suggest that eNOS may play an important role in limiting ovariectomy-induced bone remodeling as well as regulating the transition from basal modeling to remodeling.

Original languageEnglish
Pages (from-to)4392-4399
Number of pages8
JournalEndocrinology
Volume147
Issue number9
DOIs
Publication statusPublished - 2006

Fingerprint

Nitric Oxide Synthase Type III
Nitric Oxide Synthase
Ovariectomy
Bone and Bones
Bone Remodeling
Estrogens
Nitric Oxide
Mesenchymal Stromal Cells
Osteogenesis
Knockout Mice
Bone Density
Stem Cells
Endothelial Cells

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Grassi, F., Fan, X., Rahnert, J., Weitzmann, M. N., Pacifici, R., Nanes, M. S., & Rubin, J. (2006). Bone re/modeling is more dynamic in the endothelial nitric oxide synthase(-/-) mouse. Endocrinology, 147(9), 4392-4399. https://doi.org/10.1210/en.2006-0334

Bone re/modeling is more dynamic in the endothelial nitric oxide synthase(-/-) mouse. / Grassi, F.; Fan, X.; Rahnert, J.; Weitzmann, M. N.; Pacifici, R.; Nanes, M. S.; Rubin, J.

In: Endocrinology, Vol. 147, No. 9, 2006, p. 4392-4399.

Research output: Contribution to journalArticle

Grassi, F, Fan, X, Rahnert, J, Weitzmann, MN, Pacifici, R, Nanes, MS & Rubin, J 2006, 'Bone re/modeling is more dynamic in the endothelial nitric oxide synthase(-/-) mouse', Endocrinology, vol. 147, no. 9, pp. 4392-4399. https://doi.org/10.1210/en.2006-0334
Grassi, F. ; Fan, X. ; Rahnert, J. ; Weitzmann, M. N. ; Pacifici, R. ; Nanes, M. S. ; Rubin, J. / Bone re/modeling is more dynamic in the endothelial nitric oxide synthase(-/-) mouse. In: Endocrinology. 2006 ; Vol. 147, No. 9. pp. 4392-4399.
@article{4df5f112273b4665ae1abaadd2155c1b,
title = "Bone re/modeling is more dynamic in the endothelial nitric oxide synthase(-/-) mouse",
abstract = "Nitric oxide is a ubiquitous estrogen-regulated signaling molecule that has been implicated in the regulation of bone maturation and remodeling. To better understand the role that bone-cell-secreted nitric oxide plays in ovariectomy-induced modifications of bone turnover, we examined the expression of endothelial NO synthase (eNOS) in bone cells and bone progenitor cells at regular intervals up to 10 wk after acute estrogen deprivation. Ovariectomy led to an anticipated initial decline in bone cell eNOS production, but surprisingly, 17 d after ovariectomy, eNOS expression by bone and marrow stromal cells dramatically rebounded and was maintained at high levels for at least 10 wk after surgery. We examined the long-term consequences of eNOS in the process of ovariectomy-induced bone loss by prospectively analyzing bone mineral density in wild-type and eNOS(-/-) mice for 10 wk after ovariectomy. Ovariectomized eNOS(-/-) mice were observed to undergo an exaggerated state of estrogen-deficiency-induced bone remodeling compared with wild-type controls, suggesting that eNOS may act to mitigate this process. Furthermore, we found that whereas bone formation in estrogen-replete wild-type mice slowed between 14 and 20 wk of age, eNOS knockout mice continued to accrue basal bone mass at a high rate and showed no sign of entering a remodeling stage. Our data suggest that eNOS may play an important role in limiting ovariectomy-induced bone remodeling as well as regulating the transition from basal modeling to remodeling.",
author = "F. Grassi and X. Fan and J. Rahnert and Weitzmann, {M. N.} and R. Pacifici and Nanes, {M. S.} and J. Rubin",
year = "2006",
doi = "10.1210/en.2006-0334",
language = "English",
volume = "147",
pages = "4392--4399",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Bone re/modeling is more dynamic in the endothelial nitric oxide synthase(-/-) mouse

AU - Grassi, F.

AU - Fan, X.

AU - Rahnert, J.

AU - Weitzmann, M. N.

AU - Pacifici, R.

AU - Nanes, M. S.

AU - Rubin, J.

PY - 2006

Y1 - 2006

N2 - Nitric oxide is a ubiquitous estrogen-regulated signaling molecule that has been implicated in the regulation of bone maturation and remodeling. To better understand the role that bone-cell-secreted nitric oxide plays in ovariectomy-induced modifications of bone turnover, we examined the expression of endothelial NO synthase (eNOS) in bone cells and bone progenitor cells at regular intervals up to 10 wk after acute estrogen deprivation. Ovariectomy led to an anticipated initial decline in bone cell eNOS production, but surprisingly, 17 d after ovariectomy, eNOS expression by bone and marrow stromal cells dramatically rebounded and was maintained at high levels for at least 10 wk after surgery. We examined the long-term consequences of eNOS in the process of ovariectomy-induced bone loss by prospectively analyzing bone mineral density in wild-type and eNOS(-/-) mice for 10 wk after ovariectomy. Ovariectomized eNOS(-/-) mice were observed to undergo an exaggerated state of estrogen-deficiency-induced bone remodeling compared with wild-type controls, suggesting that eNOS may act to mitigate this process. Furthermore, we found that whereas bone formation in estrogen-replete wild-type mice slowed between 14 and 20 wk of age, eNOS knockout mice continued to accrue basal bone mass at a high rate and showed no sign of entering a remodeling stage. Our data suggest that eNOS may play an important role in limiting ovariectomy-induced bone remodeling as well as regulating the transition from basal modeling to remodeling.

AB - Nitric oxide is a ubiquitous estrogen-regulated signaling molecule that has been implicated in the regulation of bone maturation and remodeling. To better understand the role that bone-cell-secreted nitric oxide plays in ovariectomy-induced modifications of bone turnover, we examined the expression of endothelial NO synthase (eNOS) in bone cells and bone progenitor cells at regular intervals up to 10 wk after acute estrogen deprivation. Ovariectomy led to an anticipated initial decline in bone cell eNOS production, but surprisingly, 17 d after ovariectomy, eNOS expression by bone and marrow stromal cells dramatically rebounded and was maintained at high levels for at least 10 wk after surgery. We examined the long-term consequences of eNOS in the process of ovariectomy-induced bone loss by prospectively analyzing bone mineral density in wild-type and eNOS(-/-) mice for 10 wk after ovariectomy. Ovariectomized eNOS(-/-) mice were observed to undergo an exaggerated state of estrogen-deficiency-induced bone remodeling compared with wild-type controls, suggesting that eNOS may act to mitigate this process. Furthermore, we found that whereas bone formation in estrogen-replete wild-type mice slowed between 14 and 20 wk of age, eNOS knockout mice continued to accrue basal bone mass at a high rate and showed no sign of entering a remodeling stage. Our data suggest that eNOS may play an important role in limiting ovariectomy-induced bone remodeling as well as regulating the transition from basal modeling to remodeling.

UR - http://www.scopus.com/inward/record.url?scp=33747585583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747585583&partnerID=8YFLogxK

U2 - 10.1210/en.2006-0334

DO - 10.1210/en.2006-0334

M3 - Article

C2 - 16763060

AN - SCOPUS:33747585583

VL - 147

SP - 4392

EP - 4399

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 9

ER -